Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on February 26, 2009
Molecular Human Reproduction 2009 15(4):231-239; doi:10.1093/molehr/gap014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/4/231    most recent
gap014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Toth, B.
Right arrow Articles by Jeschke, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toth, B.
Right arrow Articles by Jeschke, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Insulin and leptin receptors as possible new candidates for endocrine control in normal and disturbed human pregnancy

Bettina Toth1,{dagger}, Anja Fischl1,2,{dagger}, Christoph Scholz2, Christina Kuhn2, Klaus Friese1,2, Maria Karamouti3, Antonis Makrigiannakis3,4,{dagger} and Udo Jeschke2,{dagger}

1Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University, 81377 Großhadern, Munich, Germany 2Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University, 80337 Maistrasse, Munich, Germany 3Laboratory of Human Reproduction, Department of Obstetrics and Gynaecology, Medical School, University of Crete, 71003 Heraklion, Greece

4 Correspondence address. Tel/Fax: +30 2810392131; E-mail: makrigia{at}med.uoc.gr

Leptin and insulin are secreted into the maternal and to a lesser extent into the fetal bloodstream where they act as placental signals and nourish the fetus, making them possible candidates for the endocrine control of the placenta. We investigated differences in leptin (LR) and insulin receptors (IR) expression in normal and disturbed first trimester human pregnancy at protein level by immunohistochemistry and at mRNA level by real-time reverse transcriptase–polymerase chain reaction (TaqMan). Highest expression of LR and IR was present in villous (VT) and extravillous trophoblasts (EVT). In hydatidiform mole trophoblasts, significantly higher LR and IR expression was observed when compared with normal pregnancy. In addition, LR and IR were also expressed in glandular epithelial cells of the decidua, again to the highest extent in hydatidiform mole when compared with normal pregnancy. With regard to abortive placentas, significant differences were also present when compared with normal first trimester placenta in the expression of LR and IR in VT, EVT and in glandular epithelial cells of the decidua. Results at protein expression of LR and IR were confirmed at mRNA level. The majority of IR and LR are expressed on structures that are currently assumed to drive placental growth. LR and IR are strongly up-regulated in placentas of hydatidiform mole and abortion. Our findings may suggest IR and LR as possible new candidates for the endocrine control of human pregnancy.

Key words: abortion/first trimester pregnancy/hydatidiform mole/insulin receptor/leptin receptor


{dagger} These authors contributed equally to this work.

Submitted on September 6, 2008; resubmitted on February 14, 2009; accepted on February 17, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.